Sökning: onr:"swepub:oai:gup.ub.gu.se/310031" > Life Expectancy Aft...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04711naa a2200373 4500 | |
001 | oai:gup.ub.gu.se/310031 | |
003 | SwePub | |
008 | 240910s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3100312 URI |
024 | 7 | a https://doi.org/10.1016/j.jacc.2021.09.8612 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Martinsson, Andreasu Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xmands |
245 | 1 0 | a Life Expectancy After Surgical Aortic Valve Replacement. |
264 | 1 | b Elsevier BV,c 2021 |
520 | a Surgical risk, age, perceived life expectancy, and valve durability influence the choice between surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation. The contemporaneous life expectancy after SAVR, in relation to surgical risk and age, is unknown.The purpose of this study was to determine median survival time in relation to surgical risk and chronological age in SAVR patients.Patients≥60 years with aortic stenosis who underwent isolated SAVR with a bioprosthesis (n=8,353) were risk-stratified before surgery into low, intermediate, or high surgical risk using the logistic EuroSCORE (2001-2011) or EuroSCORE II (2012-2017) and divided into age groups. Median survival time and cumulative 5-year mortality were estimated with Kaplan-Meier curves. Cox regression analysis was used to further determine the importance of age.There were 7,123 (85.1%) low-risk patients, 942 (11.3%) intermediate-risk patients, and 288 (3.5%) high-risk patients. Median survival time was 10.9 years (95% confidence interval: 10.6-11.2 years) in low-risk, 7.3 years (7.0-7.9years) in intermediate-risk, and 5.8 years (5.4-6.5 years) in high-risk patients. The 5-year cumulative mortality was 16.5% (15.5%-17.4%), 30.7% (27.5%-33.7%), and 43.0% (36.8%-48.7%), respectively. In low-risk patients, median survival time ranged from 16.2 years in patients aged 60 to 64 years to 6.1 years in patients aged≥85 years. Age was associated with 5-year mortality only in low-risk patients (interaction P< 0.001).Eighty-five percent of SAVR patients receiving bioprostheses have low surgical risk. Estimated survivalis substantial following SAVR, especially in younger, low-risk patients, which should be considered in Heart Teamdiscussions. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
700 | 1 | a Nielsen, Susanne,d 1969u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xniesu |
700 | 1 | a Milojevic, Milan4 aut |
700 | 1 | a Redfors, Björnu Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberg Laboratory,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xredbj |
700 | 1 | a Omerovic, Elmir,d 1968u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberg Laboratory,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xomeel |
700 | 1 | a Tönnessen, Theis4 aut |
700 | 1 | a Gudbjartsson, Tomas4 aut |
700 | 1 | a Dellgren, Göran,d 1961u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xdelgo |
700 | 1 | a Jeppsson, Anders,d 1960u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberglaboratoriet,Institute of Medicine, Department of Molecular and Clinical Medicine,Wallenberg Laboratory4 aut0 (Swepub:gu)xjepan |
710 | 2 | a Göteborgs universitetb Institutionen för medicin, avdelningen för molekylär och klinisk medicin4 org |
773 | 0 | t Journal of the American College of Cardiologyd : Elsevier BVg 78:22, s. 2147-2157q 78:22<2147-2157x 1558-3597x 0735-1097 |
856 | 4 | u https://doi.org/10.1016/j.jacc.2021.09.861 |
856 | 4 8 | u https://gup.ub.gu.se/publication/310031 |
856 | 4 8 | u https://doi.org/10.1016/j.jacc.2021.09.861 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy